• 鄭州大學(xué)第一附屬醫(yī)院呼吸科(河南鄭州 450052);

目的  了解非中性粒細(xì)胞缺乏患者發(fā)生侵襲性曲霉?。↖A)的危險(xiǎn)因素、臨床特征及預(yù)后。方法  根據(jù)歐洲癌癥研究和治療侵襲性真菌感染協(xié)作組以及美國(guó)變態(tài)反應(yīng)和感染性疾病學(xué)會(huì)真菌病研究組(EORTC/MSG)2002年的定義及我國(guó)侵襲性肺曲霉病的分級(jí)診斷標(biāo)準(zhǔn),納入鄭州大學(xué)第一附屬醫(yī)院2001年1月~2006年12月診斷的54例IA患者(其中確診9例,臨床診斷30例,擬診15例),進(jìn)行回顧性分析。結(jié)果  中性粒細(xì)胞缺乏組24例,其中20例為血液系統(tǒng)惡性腫瘤患者;非中性粒細(xì)胞缺乏組30例,11例為接受激素治療的慢性阻塞性肺疾?。–OPD)患者。發(fā)熱、胸悶、咳嗽、胸痛、咯血為常見(jiàn)癥狀。胸部CT顯示節(jié)段性肺實(shí)變?cè)谥行粤<?xì)胞缺乏組多見(jiàn),非中性粒細(xì)胞缺乏組則以多發(fā)結(jié)節(jié)陰影為主。結(jié)節(jié)或?qū)嵶冇皟?nèi)空洞形成較暈輪征、新月征更常見(jiàn)。IA總體病死率達(dá)72.2%,非中性粒細(xì)胞缺乏組高于中性粒細(xì)胞缺乏組(83.3%比58.3%,P=0.042)。預(yù)后危險(xiǎn)因素分析表明,繼發(fā)中樞神經(jīng)系統(tǒng)IA及延遲診斷與預(yù)后有關(guān)。結(jié)論  非中性粒細(xì)胞缺乏患者發(fā)生IA并非少見(jiàn),病死率高,接受激素治療的COPD患者是發(fā)生IA的主要危險(xiǎn)因素。

引用本文: 陳瑞英,靳建軍,歐陽(yáng)松云,孫培宗. 非中性粒細(xì)胞缺乏患者發(fā)生侵襲性曲霉病的危險(xiǎn)因素、臨床特征及預(yù)后分析. 中國(guó)呼吸與危重監(jiān)護(hù)雜志, 2008, 08(3): 169-173. doi: 復(fù)制

1. Vaideeswar P,Prasad S,Deshpande JR,et al.Invasive pulmonary aspergillosis:A study of 39 cases at autopsy.J Postgrad Med,2004,50:21-26.
2. Patterson TF,Kirkpatrick WR,White M,et al.Invasive aspergillosis.Disease spectrum,treatment practices,and outcome.13 Aspergillus Study Group.Medicine(Baltimore),2000,79:250-260.
3. Ader F,Nseir S,Le Berre R,et al.Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease:an emerging fungal pathogen.Clin Microbiol Infect,2005,11:427-429.
4. Denning DW.Aspergillosis in “nonimmunocompromised” critically ill patients.Am J Respir Crit Care Med,2004,170:580-581.
5. Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14.
6. 朱小敏,周新.侵襲性肺曲霉病的診斷與治療.中國(guó)呼吸與危重監(jiān)護(hù)雜志,2005,4:316-320.
7. Allam MF,Del Castillo AS,Diaz-Molina C,et al.Invasive pulmonary aspergillosis:identification of risk factors.Scand J Infect Dis,2002,34:819-822.
8. Bulpa PA,Dive AM,Garrino MG,et al.Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis:benefits of intensive care? Intensive Care Med,2001,27:59-67.
9. Rello J,Esandi ME,Mariscal D,et al.Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease:report of eight cases and review.Clin Infect Dis,1998,26:1473-1475.
10. Garcés Jarque JM,Terradas Robledo R,Alvarez-Lerma F,et al.Lung aspergillosis.Role of the corticoids as associated risk factor in the patient with chronic bronchitis.Rev Clin Esp,2003,203:472-474.
11. 陳瑞英,孫培宗,靳建軍,等.原發(fā)性侵襲性肺曲霉病四例分析.中國(guó)呼吸與危重監(jiān)護(hù)雜志,2007,6,385-387.
12. Clancy CJ,Nguyen MH.Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts:clues for recognition of a rare but fatal disease.Chest,1998,114:629-634.
13. Denning DW:Aspergillus species.In Principles and Practice of Infectious Disease Edited by:Mandell G,Douglas J,Bennett D.Philadelphia:Churchill Livingstone:2000:2675-2685.
14. Yu VL,Muder RR,Poorsattar A.Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis.Results from a three-year prospective study.Am J Med,1986,81:249-254.
  1. 1. Vaideeswar P,Prasad S,Deshpande JR,et al.Invasive pulmonary aspergillosis:A study of 39 cases at autopsy.J Postgrad Med,2004,50:21-26.
  2. 2. Patterson TF,Kirkpatrick WR,White M,et al.Invasive aspergillosis.Disease spectrum,treatment practices,and outcome.13 Aspergillus Study Group.Medicine(Baltimore),2000,79:250-260.
  3. 3. Ader F,Nseir S,Le Berre R,et al.Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease:an emerging fungal pathogen.Clin Microbiol Infect,2005,11:427-429.
  4. 4. Denning DW.Aspergillosis in “nonimmunocompromised” critically ill patients.Am J Respir Crit Care Med,2004,170:580-581.
  5. 5. Ascioglu S,Rex JH,de Pauw B,et al.Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants:an international consensus.Clin Infect Dis,2002,34:7-14.
  6. 6. 朱小敏,周新.侵襲性肺曲霉病的診斷與治療.中國(guó)呼吸與危重監(jiān)護(hù)雜志,2005,4:316-320.
  7. 7. Allam MF,Del Castillo AS,Diaz-Molina C,et al.Invasive pulmonary aspergillosis:identification of risk factors.Scand J Infect Dis,2002,34:819-822.
  8. 8. Bulpa PA,Dive AM,Garrino MG,et al.Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis:benefits of intensive care? Intensive Care Med,2001,27:59-67.
  9. 9. Rello J,Esandi ME,Mariscal D,et al.Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease:report of eight cases and review.Clin Infect Dis,1998,26:1473-1475.
  10. 10. Garcés Jarque JM,Terradas Robledo R,Alvarez-Lerma F,et al.Lung aspergillosis.Role of the corticoids as associated risk factor in the patient with chronic bronchitis.Rev Clin Esp,2003,203:472-474.
  11. 11. 陳瑞英,孫培宗,靳建軍,等.原發(fā)性侵襲性肺曲霉病四例分析.中國(guó)呼吸與危重監(jiān)護(hù)雜志,2007,6,385-387.
  12. 12. Clancy CJ,Nguyen MH.Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts:clues for recognition of a rare but fatal disease.Chest,1998,114:629-634.
  13. 13. Denning DW:Aspergillus species.In Principles and Practice of Infectious Disease Edited by:Mandell G,Douglas J,Bennett D.Philadelphia:Churchill Livingstone:2000:2675-2685.
  14. 14. Yu VL,Muder RR,Poorsattar A.Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis.Results from a three-year prospective study.Am J Med,1986,81:249-254.
  • 上一篇

    快速預(yù)氧在婦產(chǎn)科門診手術(shù)中的應(yīng)用
  • 下一篇

    腦靜脈及靜脈竇血栓形成的預(yù)后研究